In gastric cancer, high DLL4 levels reasonably resulted in hyperactivation of Notch1 signaling and were associated with poorer clinical outcome, stem-cell-like phenotype and 5-FU resistance [560]. This evidence concerns the gene NOTCH1 and gastric cancer.